Table 1. Hematologic Malignancies Detection Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Hematologic Malignancies Detection Market Restraints

Table 3. Hematologic Malignancies Detection Market Trends

Table 4. Hematologic Malignancies Detection Industry Policy

Table 5. Global Hematologic Malignancies Detection Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Hematologic Malignancies Detection Revenue Market Share by Company (2018-2023)

Table 7. Global Hematologic Malignancies Detection Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Hematologic Malignancies Detection Mergers & Acquisitions, Expansion Plans

Table 9. Global Hematologic Malignancies Detection Manufacturers Product Type

Table 10. China Hematologic Malignancies Detection Revenue by Company (2018-2023) & (US$ million)

Table 11. China Hematologic Malignancies Detection Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Hematologic Malignancies Detection Upstream (Raw Materials)

Table 13. Global Hematologic Malignancies Detection Typical Customers

Table 14. Hematologic Malignancies Detection Typical Distributors

Table 15. By Type, Global Hematologic Malignancies Detection Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Hematologic Malignancies Detection Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Hematologic Malignancies Detection Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Hematologic Malignancies Detection Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Hematologic Malignancies Detection Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Hematologic Malignancies Detection Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Hematologic Malignancies Detection Revenue Market Share, 2018-2029

Table 22. ArcherDx Company Information, Head Office, Market Area and Industry Position

Table 23. ArcherDx Company Profile and Main Business

Table 24. ArcherDx Hematologic Malignancies Detection Models, Specifications and Application

Table 25. ArcherDx Hematologic Malignancies Detection Revenue and Gross Margin, 2018-2023

Table 26. ArcherDx Recent Developments

Table 27. Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position

Table 28. Bio-Rad Laboratories Company Profile and Main Business

Table 29. Bio-Rad Laboratories Hematologic Malignancies Detection Models, Specifications and Application

Table 30. Bio-Rad Laboratories Hematologic Malignancies Detection Revenue and Gross Margin, 2018-2023

Table 31. Bio-Rad Laboratories Recent Developments

Table 32. sysmex Company Information, Head Office, Market Area and Industry Position

Table 33. sysmex Company Profile and Main Business

Table 34. sysmex Hematologic Malignancies Detection Models, Specifications and Application

Table 35. sysmex Hematologic Malignancies Detection Revenue and Gross Margin, 2018-2023

Table 36. sysmex Recent Developments

Table 37. Invitae Company Information, Head Office, Market Area and Industry Position

Table 38. Invitae Company Profile and Main Business

Table 39. Invitae Hematologic Malignancies Detection Models, Specifications and Application

Table 40. Invitae Hematologic Malignancies Detection Revenue and Gross Margin, 2018-2023

Table 41. Invitae Recent Developments

Table 42. NeoGenomics Laboratories Company Information, Head Office, Market Area and Industry Position

Table 43. NeoGenomics Laboratories Company Profile and Main Business

Table 44. NeoGenomics Laboratories Hematologic Malignancies Detection Models, Specifications and Application

Table 45. NeoGenomics Laboratories Hematologic Malignancies Detection Revenue and Gross Margin, 2018-2023

Table 46. NeoGenomics Laboratories Recent Developments

Table 47. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

Table 48. Abbott Laboratories Company Profile and Main Business

Table 49. Abbott Laboratories Hematologic Malignancies Detection Models, Specifications and Application

Table 50. Abbott Laboratories Hematologic Malignancies Detection Revenue and Gross Margin, 2018-2023

Table 51. Abbott Laboratories Recent Developments

Table 52. Cancer Genetics Company Information, Head Office, Market Area and Industry Position

Table 53. Cancer Genetics Company Profile and Main Business

Table 54. Cancer Genetics Hematologic Malignancies Detection Models, Specifications and Application

Table 55. Cancer Genetics Hematologic Malignancies Detection Revenue and Gross Margin, 2018-2023

Table 56. Cancer Genetics Recent Developments

Table 57. Adaptive Biotechnologies Corporation Company Information, Head Office, Market Area and Industry Position

Table 58. Adaptive Biotechnologies Corporation Company Profile and Main Business

Table 59. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Models, Specifications and Application

Table 60. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Revenue and Gross Margin, 2018-2023

Table 61. Adaptive Biotechnologies Corporation Recent Developments

Table 62. Asuragen Company Information, Head Office, Market Area and Industry Position

Table 63. Asuragen Company Profile and Main Business

Table 64. Asuragen Hematologic Malignancies Detection Models, Specifications and Application

Table 65. Asuragen Hematologic Malignancies Detection Revenue and Gross Margin, 2018-2023

Table 66. Asuragen Recent Developments

Table 67. Invivoscribe Company Information, Head Office, Market Area and Industry Position

Table 68. Invivoscribe Company Profile and Main Business

Table 69. Invivoscribe Hematologic Malignancies Detection Models, Specifications and Application

Table 70. Invivoscribe Hematologic Malignancies Detection Revenue and Gross Margin, 2018-2023

Table 71. Invivoscribe Recent Developments

Table 72. Nanjing Shihejiyin Technology Company Information, Head Office, Market Area and Industry Position

Table 73. Nanjing Shihejiyin Technology Company Profile and Main Business

Table 74. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Models, Specifications and Application

Table 75. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Revenue and Gross Margin, 2018-2023

Table 76. Nanjing Shihejiyin Technology Recent Developments

Table 77. Annaroad Gene Technology Company Information, Head Office, Market Area and Industry Position

Table 78. Annaroad Gene Technology Company Profile and Main Business

Table 79. Annaroad Gene Technology Hematologic Malignancies Detection Models, Specifications and Application

Table 80. Annaroad Gene Technology Hematologic Malignancies Detection Revenue and Gross Margin, 2018-2023

Table 81. Annaroad Gene Technology Recent Developments

Table 82. BGI Genomics Company Information, Head Office, Market Area and Industry Position

Table 83. BGI Genomics Company Profile and Main Business

Table 84. BGI Genomics Hematologic Malignancies Detection Models, Specifications and Application

Table 85. BGI Genomics Hematologic Malignancies Detection Revenue and Gross Margin, 2018-2023

Table 86. BGI Genomics Recent Developments

List of Figure

Figure 1. Hematologic Malignancies Detection Picture

Figure 2. Global Hematologic Malignancies Detection Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Hematologic Malignancies Detection Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Hematologic Malignancies Detection Market Share of Global

Figure 5. Global Hematologic Malignancies Detection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Hematologic Malignancies Detection Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Hematologic Malignancies Detection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Hematologic Malignancies Detection Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Hematologic Malignancies Detection Industry Chain

Figure 10. Polymerase Chain Reaction

Figure 11. Immunochemistry

Figure 12. Next Generation Sequencing

Figure 13. Fluorescence in Situ Hybridization

Figure 14. Others

Figure 15. By Type, Global Hematologic Malignancies Detection Revenue, 2018-2029, US$ Million

Figure 16. By Type, Global Hematologic Malignancies Detection Revenue Market Share, 2018-2029

Figure 17. Multiple Myeloma

Figure 18. Myelodysplastic Syndrome

Figure 19. Leukemia

Figure 20. Myeloproliferative Neoplasms

Figure 21. Lymphoma

Figure 22. Others

Figure 23. By Application, Global Hematologic Malignancies Detection Revenue, 2018-2029, US$ Million

Figure 24. By Application, Global Hematologic Malignancies Detection Revenue Market Share, 2018-2029

Figure 25. By Region, Global Hematologic Malignancies Detection Revenue Market Share, 2018-2029

Figure 26. North America Hematologic Malignancies Detection Revenue & Forecasts, 2018-2029, US$ Million

Figure 27. By Country, North America Hematologic Malignancies Detection Revenue Market Share, 2018-2023

Figure 28. Europe Hematologic Malignancies Detection Revenue & Forecasts, 2018-2029, US$ Million

Figure 29. By Country, Europe Hematologic Malignancies Detection Revenue Market Share, 2018-2023

Figure 30. Asia Pacific Hematologic Malignancies Detection Revenue & Forecasts, 2018-2029, US$ Million

Figure 31. By Country/Region, Asia Pacific Hematologic Malignancies Detection Revenue Market Share, 2018-2023

Figure 32. South America Hematologic Malignancies Detection Revenue & Forecasts, 2018-2029, US$ Million

Figure 33. By Country, South America Hematologic Malignancies Detection Revenue Market Share, 2018-2023

Figure 34. Middle East & Africa Hematologic Malignancies Detection Revenue & Forecasts, 2018-2029, US$ Million

Figure 35. U.S. Hematologic Malignancies Detection Revenue, 2018-2029, (US$ Million)

Figure 36. By Company, U.S. Hematologic Malignancies Detection Market Share, 2018-2023

Figure 37. By Type, U.S. Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 38. By Application, U.S. Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 39. Europe Hematologic Malignancies Detection Revenue, 2018-2029, (US$ Million)

Figure 40. By Company, Europe Hematologic Malignancies Detection Market Share, 2018-2023

Figure 41. By Type, Europe Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 42. By Application, Europe Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 43. China Hematologic Malignancies Detection Revenue, 2018-2029, (US$ Million)

Figure 44. By Company, China Hematologic Malignancies Detection Market Share, 2018-2023

Figure 45. By Type, China Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 46. By Application, China Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 47. Japan Hematologic Malignancies Detection Revenue, 2018-2029, (US$ Million)

Figure 48. By Company, Japan Hematologic Malignancies Detection Market Share, 2018-2023

Figure 49. By Type, Japan Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 50. By Application, Japan Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 51. South Korea Hematologic Malignancies Detection Revenue, 2018-2029, (US$ Million)

Figure 52. By Company, South Korea Hematologic Malignancies Detection Market Share, 2018-2023

Figure 53. By Type, South Korea Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 54. By Application, South Korea Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 55. Southeast Asia Hematologic Malignancies Detection Revenue, 2018-2029, (US$ Million)

Figure 56. By Company, Southeast Asia Hematologic Malignancies Detection Market Share, 2018-2023

Figure 57. By Type, Southeast Asia Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 58. By Application, Southeast Asia Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 59. India Hematologic Malignancies Detection Revenue, 2018-2029, (US$ Million)

Figure 60. By Company, India Hematologic Malignancies Detection Market Share, 2018-2023

Figure 61. By Type, India Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 62. By Application, India Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 63. Middle East & Asia Hematologic Malignancies Detection Revenue, 2018-2029, (US$ Million)

Figure 64. By Company, Middle East & Asia Hematologic Malignancies Detection Market Share, 2018-2023

Figure 65. By Type, Middle East & Asia Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 66. By Application, Middle East & Asia Hematologic Malignancies Detection Revenue Market Share, 2022 VS 2029

Figure 67. Research Methodology

Figure 68. Breakdown of Primary Interviews

Figure 69. Bottom-up Approaches

Figure 70. Top-down Approaches